P2 receptor-mediated inhibition of adenylyl cyclase in PC12 cells

被引:7
作者
Murayama, T [1 ]
Yakushi, Y [1 ]
Watanabe, A [1 ]
Nomura, Y [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 060, Japan
关键词
PC12; cell; ATP; cAMP; P2Y receptor;
D O I
10.1016/S0014-2999(98)00130-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PC12 pheochromocytoma cells have P2 receptors which are coupled to Ca2+ influx and catecholamine release. Previously we reported that ATP stimulated cyclic AMP accumulation at low concentrations up to 100 mu M but showed inhibitory effects above this concentration [Yakushi, Y., Watanabe, A., Murayama, T., Nomura, Y., 1996. Eur. J. Pharmacol. (314) 243-248]. In this study we investigated the characteristics of the inhibitory effects of ATP analogs. In the presence of 10 mu M forskolin, an activator of adenylyl cyclase, ATP, adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S), 2',3'-O-(4-benzoyl) benzoyl ATP, 2-methylthio ATP and adenosine 5'-O-(2-thiodiphosphate) inhibited cyclic AMP accumulation in a dose-dependent manner from 100 mu M. UTP, alpha beta and beta gamma-methylene ATP had no or very limited effects. The relative order of ATP analogs suggests that the ATP receptor appears to be P2Y-like. However, suramin, an antagonist of P2X and P2Y receptors, and reactive blue-2, which inhibited beta gamma-methylene ATP-induced cyclic AMP accumulation, did not modify the inhibitory effect of ATP gamma S. Treatment with pertussis toxin, which completely abolished the effect of carbachol, had no effect on the action of ATP over 300 mu M. The existence of a new type of ATP receptor-mediated inhibition of adenylyl cyclase is proposed in PC12 cells. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 41 条
[1]   Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells [J].
Akbar, GKM ;
Dasari, VR ;
Webb, TE ;
Ayyanathan, K ;
Pillarisetti, K ;
Sandhu, AK ;
Athwal, RS ;
Daniel, JL ;
Ashby, B ;
Barnard, EA ;
Kunapuli, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18363-18367
[2]  
BOYER JL, 1993, J PHARMACOL EXP THER, V267, P1140
[3]   NEW STRUCTURAL MOTIF FOR LIGAND-GATED ION CHANNELS DEFINED BY AN IONOTROPIC ATP RECEPTOR [J].
BRAKE, AJ ;
WAGENBACH, MJ ;
JULIUS, D .
NATURE, 1994, 371 (6497) :519-523
[4]   MOLECULAR-CLONING AND FUNCTIONAL-ANALYSIS OF A NOVEL P-2 NUCLEOTIDE RECEPTOR [J].
CHANG, KG ;
HANAOKA, K ;
KUMADA, M ;
TAKUWA, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26152-26158
[5]   Cloning and functional expression of a human uridine nucleotide receptor [J].
Communi, D ;
Pirotton, S ;
Parmentier, M ;
Boeynaems, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :30849-30852
[6]   Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase [J].
Communi, D ;
Govaerts, C ;
Parmentier, M ;
Boeynaems, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :31969-31973
[7]  
DALZIEL HH, 1994, PHARMACOL REV, V46, P449
[8]   CALCIUM IS AN INHIBITOR OF LUTEINIZING HORMONE-SENSITIVE ADENYLATE-CYCLASE IN THE LUTEAL CELL [J].
DORFLINGER, LJ ;
ALBERT, PJ ;
WILLIAMS, AT ;
BEHRMAN, HR .
ENDOCRINOLOGY, 1984, 114 (04) :1208-1215
[9]   EXTRACELLULAR ATP AND CELL SIGNALING [J].
ELMOATASSIM, C ;
DORNAND, J ;
MANI, JC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1134 (01) :31-45
[10]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143